Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug ...

We can no longer afford to view wildfire smoke exposure as an isolated event. It is a growing cardiovascular threat—one that ...

As members of the harm reduction working group of the Alcohol Tobacco and Other Drugs Section of the American Public Health ...

A primary challenge in finally achieving high value healthcare in the US is discovering how to harness the comprehensive and ...

Analysis For each drug’s indications, and to mirror the FDA’s call in the action plan that clinical trial enrollment should mirror prevalence, we compared the share of Black and White patients ...

With more than a fifth of kidneys now allocated outside the established order, serious concerns about transparency, fairness, ...

Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements ...

Beneficiaries’ initial enrollment choices, whether active or passive, tend to have long-lasting implications because ...

Meghan Bellerose ([email protected]), Columbia University Mailman School of Public Health, New York, New York. Lauren Collin, Columbia University Mailman School of Public Health. Jamie R.

Kristie L. Ebi ([email protected]) is a professor in the Department of Global Health at the University of Washington, in Seattle. Jeremy J. Hess is a professor of environmental and occupational ...

An up-to-date assessment of environmental emissions in the US health care sector is essential to help policy makers hold the health care industry accountable to protect public health. We update ...

Patient And Hospital Characteristics Patients’ demographic characteristics used for risk adjustment included age, sex, and twenty-nine comorbidities collected by the Nationwide Readmissions ...